Spore.Bio has developed technology that utilizes AI to immediately identify bacteria in consumer products. The company was founded in 2023 by Amine Raji , CEO, Maxime Mistretta, Ph.D., CTO and Mohamed Tazi, COO due to the complexities surrounding consumer product safety.
The device uses advanced machine learning models to train its system to identify the concentration of bacteria in food, drink, pharmaceuticals and cosmetic products before alerting quality managers to the potential risks, per the company.
The technology not only reduces cross-contamination risks and costs but allows manufacturers to address sources of contamination before they pose a public health risk, per the company.
Related: Air Pollution from Wildfires Stirs Skin Flare-ups in Northeastern U.S., Study Suggests
Raji commented: "Our mission is to redefine microbiology and to bring 21st-century technology to an age-old problem. The risks around pathogens in FMCGs are only growing, causing needless suffering for families and detrimental effects on the reputations and finances of global companies. We’re changing the status quo with Spore.Bio by combining AI and our deep expertise in this space."
Julia Hawkins, general partner at LocalGlobe, commented: “Spore.Bio’s innovation is where photonics and AI meet the same level of bacterial detection as traditional methods, in real-time. It’s not just a technological advancement; it's a stride towards a safer, healthier society and a clear case of how AI can solve real, industrial problems."
